Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…Diego, CA, USA.Wang D, Shinde V, Singh M, Brake R, Kolodziej A. CRB-601, an αvβ8 blocking antibody, prevents activation of TGFβ and exh…
… OS was not reached.Conclusions Intrathecal PD-1 inhibitor plus pemetrexed showed feasibility for LM from solid tumors with potential acti…
… tumors and tumor draining lymph nodes to unveil the effects of APMV-4 ISV on host immune responses. Ex vivo splenocyte stimulation wa…
…usted CD8+ T cells and enhanced anti-tumor immunity.Conclusions ABT-863 is a first-in-class CCR8 inverse agonist antibody that promotes…
…stereotactic body radiotherapy (SBRT) in a preclinical model of triple-negative breast cancer (TNBC). Given that T cell function is a key variable underlying…
…edgements CBD-IL-7 and CBD-IL-12 generated by Dr. Jun Ishihara, Imperial College London.Ethics Approval This study was approved by the Institutional An…
…to assess the safety and efficacy of the multikinase inhibitor, sorafenib, combined with ICI nivolumab (anti-PD-1), in 16 patients with H…
…us community settings.Acknowledgements This study was funded by AstraZeneca. Medical writing support for the development of this abstract, …
…rrow niche alterations and hematopoietic clonal dynamicsResults Melanoma tumor cells infiltrate the bone marrow early, with disseminated…
… by The Institutitonal Animal Care and Use Committee (IACUC) at The Scripps Research Institute (TSRI), in accordance with NIH guidelines. De-identified human …
…s.Acknowledgements Biorepository and Molecular Pathology Core – Huntsman Cancer Institute, São Paulo Research Foundation - FAPESP, grant number: 2023/147…
…he potential of artLCMV as a promising therapeutic strategy for peritoneal carcinomatosis, offering durable expression and potent antitumor effects. The …